Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus
- Status
- COMPLETED
- Phase
- PHASE3
Prospective Sexual Function Study for BPH Subjects
- Status
- COMPLETED
- Phase
- PHASE4
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Safety of GSK2398852 When Co-administered With GSK2315698 in Patients With Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1
A Long-term, Safety, Tolerability, and Efficacy Study of Retigabine Immediate-release (IR) in Asian Adults With Partial Onset Seizures
- Status
- COMPLETED
- Phase
- PHASE3
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians
- Status
- COMPLETED
- Phase
- N/A
An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Bioequivalence Study of an Amoxicillin-Clavulanic
- Status
- COMPLETED
- Phase
- PHASE1
NSCLC Burden of Illness Study
- Status
- COMPLETED
- Phase
- N/A
Bioequivalence Study for Terbinafine 250 mg
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of the Addition of Fluticasone Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide Inhalation Powder (62.5 or 125mcg) Once-daily Over 12 Weeks.
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of the Addition of Fluticanse Propionate/Salmeterol (250/50mcg) Twice-daily to 2 Doses of Umeclidinium Bromide (62.5 or 125mcg) Once-daily Over 12 Weeks
- Status
- COMPLETED
- Phase
- PHASE3
Training Study to Characterise Biomarkers to the Engerix B Vaccine
- Status
- COMPLETED
- Phase
- NA
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Bioequivalence Study of Cephalexin Tablets 1g
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Cephalexin Suspension 250
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Cephalexin Suspension 125
- Status
- COMPLETED
- Phase
- PHASE1